Article Versions Notes

Urias BS, Pavan AR, Albuquerque GR, Prokopczyk IM, Alves TMF, de Melo TRF, Sartori GR, da Silva JHM, Chin CM, Santos JLD. Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors. Pharmaceuticals. 2022; 15(10):1260. https://doi.org/10.3390/ph15101260

Urias, Beatriz Silva, Aline Renata Pavan, Gabriela Ribeiro Albuquerque, Igor Muccilo Prokopczyk, Tânia Mara Ferreira Alves, Thais Regina Ferreira de Melo, Geraldo Rodrigues Sartori, João Hermínio Martins da Silva, Chung Man Chin, and Jean Leandro Dos Santos. 2022. "Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors" Pharmaceuticals 15, no. 10: 1260. https://doi.org/10.3390/ph15101260

Urias, B. S., Pavan, A. R., Albuquerque, G. R., Prokopczyk, I. M., Alves, T. M. F., de Melo, T. R. F., Sartori, G. R., da Silva, J. H. M., Chin, C. M., & Santos, J. L. D. (2022). Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors. Pharmaceuticals, 15(10), 1260. https://doi.org/10.3390/ph15101260